Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 143Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Abbott Laboratories

02 2Aeon Formulations Private Limited

03 1Anwita Drugs & Chemicals Pvt Ltd

04 1Aspire Lifesciences Pvt Ltd

05 1Avenza Pharmaceuticals

06 3Bio Labs

07 1Biodeal Pharmaceuticals

08 3Globofarm International

09 1Hanlim Pharmaceuticals Inc

10 2Health Biotech

11 1Kolmar Korea Co., Ltd.

12 1Laboratorios Salvat

13 2Lucent Biotech Ltd

14 1Myungmoon Pharm. Co., LTD.

15 2Pelcoat Formulations

16 1RELIANCE FORMULATION PVT. LTD

17 3Suncare Formulations

18 2TEOFARMA Srl

19 3THERABEL GIENNE PHARMA SpA

20 2Zota Healthcare Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levopraid

Dosage Form :

Dosage Strength : 20 Cpr 25 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levopraid

Dosage Form :

Dosage Strength : Gtt Os 20 Ml 2.5%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levopraid 50

Dosage Form :

Dosage Strength : 20 Cpr 50 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levopraid 100

Dosage Form :

Dosage Strength : 20 Cpr 100 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Esomeprazole; levosulpiride

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 40MG; 75MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride; Rabeprazole

Brand Name :

Dosage Form : CAPSULE CONTAINING EC & SR PELLETS

Dosage Strength : 20MG; 75MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name :

Dosage Form : SR Pellet

Dosage Strength : 60%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Rabeprazole; Levosulpiride

Brand Name :

Dosage Form : Pellets

Dosage Strength : 20MG; 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Evosol

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 2x10's

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Pakistan

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Evosol

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 2x10's

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Pakistan

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Evosol

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 2x10's

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Pakistan

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : LEVOPULSID

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 30T, 500T

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Korea

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levosulpiride

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic B.E study

Registration Country : South Korea

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name :

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

16

TEOFARMA Srl

Country
2024 ACI Convention
Not Confirmed
arrow

TEOFARMA Srl

Country
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Lopraid

Dosage Form : Levosulpiride 25Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 25 mg 2 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

17

THERABEL GIENNE PHARMA SpA

Country
2024 ACI Convention
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Lobren

Dosage Form : Levosulpiride 25Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 2 ml 12.5 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

18

TEOFARMA Srl

Country
2024 ACI Convention
Not Confirmed
arrow

TEOFARMA Srl

Country
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Lopraid

Dosage Form : Levosulpiride 50Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 50 mg 2 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

19

THERABEL GIENNE PHARMA SpA

Country
2024 ACI Convention
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levobren

Dosage Form :

Dosage Strength : 20 Cpr 25 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

20

THERABEL GIENNE PHARMA SpA

Country
2024 ACI Convention
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
2024 ACI Convention
Not Confirmed

levosulpiride

Brand Name : Levobren

Dosage Form :

Dosage Strength : Gtt Os 20 Ml 2.5%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank